Lactobacillus GG treatment during pregnancy for the prevention of eczema: A randomized controlled trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 4, 2011, Pages 509-516

  Boyle, R J ^a,b   Ismail, I H ^a,b   Kivivuori, S ^a   Licciardi, P V ^a   Robins Browne, R M ^b   Mah, L J ^a   Axelrad, C ^a,c   Moore, S ^a,c   Donath, S ^b,d   Carlin, J B ^b,d   Lahtinen, S J ^a,e,f   Tang, M L K ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF TURKU   (Finland)

^f Danisco Finland Oy   (Finland)

Author keywords

Breast milk; Cord blood; Eczema; Immune; Pregnancy; Probiotic

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; LACTOBACILLUS RHAMNOSUS GG; PLACEBO; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLERGIC DISEASE; ARTICLE; BREAST MILK; CESAREAN SECTION; DENDRITIC CELL; ECZEMA; FEMALE; FOLLOW UP; HIGH RISK INFANT; HUMAN; LACTOBACILLUS RHAMNOSUS; NEWBORN; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; UMBILICAL CORD BLOOD;

ADULT; ECZEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; INFANT; LACTOBACILLUS RHAMNOSUS; MIDDLE AGED; MILK, HUMAN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROBIOTICS; YOUNG ADULT;

EID: 79952021189     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02507.x     Document Type: Article

References (35)

1. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-134. (Pubitemid 32105256)
2. Boyle RJ, Tang ML. Can allergic diseases be prevented prenatally? Allergy 2006;61: 1423-1431.
3. Ege MJ, Bieli C, Frei R, van Strien RT, Riedler J, Ublagger E et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006;117:817-823.
4. Abrahamsson TR, Jakobsson T, Bottcher MF, Fredrikson M, Jenmalm MC, Bjorksten B et al. Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119:1174-1180. (Pubitemid 46654165)
5. Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy 2008;38:1342-1348. (Pubitemid 352019662)
6. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-1079. (Pubitemid 32322538)
7. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008;121:e850-856.
8. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009;123:335-341.
9. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007;119:184-191. (Pubitemid 46037800)
10. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008;122:788-794.
11. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 2006;60:221-224. (Pubitemid 44297597)
12. Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden N et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009;64:1349-1358.
13. Soh SE, Aw M, Gerez I, Chong YS, Rauff M, Ng YP et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009;39:571-578.
14. West CE, Hammarstrom ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009;20:430-437.
15. Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010;21:e386-93.
16. Dotterud C, Oien T, Storro O, Johnsen R. Probiotic supplementation given to mothers in primary prevention of allergic diseases in early childhood - a randomised, double blind, placebo controlled trial in a nonselected population. Allergy 2009;64(S90):1-98.
17. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007;4:CD006475.
18. Prescott SL, Bjorksten B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007;120:255-262. (Pubitemid 47102387)
19. Lahtinen SJ, Boyle RJ, Kivivuori S, Oppedisano F, Smith KR, Robins-Browne R et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol 2009;123:499-501.
20. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebocontrolled trial. J Allergy Clin Immunol 2007;119:192-198. (Pubitemid 46037805)
21. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-416. (Pubitemid 24290228)
22. Fleming S, Bodner C, Devereux G, Russell G, Campbell D, Godden D et al. An application of the United Kingdom Working Party diagnostic criteria for atopic dermatitis in Scottish infants. J Invest Dermatol 2001;117:1526-1530. (Pubitemid 34032783)
23. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000;343:538-543. (Pubitemid 30654817)
24. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241. (Pubitemid 38962578)
25. Jones CA, Holloway JA, Popplewell EJ, Diaper ND, Holloway JW, Vance GH et al. Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 2002; 109:858-866. (Pubitemid 34499522)
26. Oddy WH, Rosales F. A systematic review of the importance of milk TGF-beta on immunological outcomes in the infant and young child. Pediatr Allergy Immunol 2010;21:47-59.
27. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109:119-121. (Pubitemid 34112140)
28. Neaville WA, Tisler C, Bhattacharya A, Anklam K, Gilbertson-White S, Hamilton R et al. Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. J Allergy Clin Immunol 2003;112:740-746. (Pubitemid 37260391)
29. Blumer N, Sel S, Virna S, Patrascan CC, Zimmermann S, Herz U et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 2007;37:348-357. (Pubitemid 46393247)
30. Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy 2008;38:1606-1614.
31. Boyle RJ, Mah LJ, Chen A, Kivivuori S, Robins-Browne RM, Tang ML. Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen-specific immune responses. Clin Exp Allergy 2008;38:1882-1890.
32. Gore C, Munro K, Lay C, Bibiloni R, Morris J, Woodcock A et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 2008;121:135-140.
33. Suzuki S, Shimojo N, Tajiri Y, Kumemura M, Kohno Y. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007;37:506-511. (Pubitemid 46537739)
34. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005;115:5-9. (Pubitemid 43046274)
35. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006;83:1256-1264.